Summary
The MARKinPATH project aims to undertake the clinical validation of Xylose, after ingestion of Gaxilose, as a Biomarker of intestinal conditions and pathologies. Currently, the measurement of Xylose after ingestion of Gaxilose is used to diagnose hypolactasia in adults...
More information & hyperlinks
| Web resources: | http://www.venterpharma.com |